Nephroticc syndromes result from increased glomerular permeability to proteins and are structurally believedd to be associated with podocyte foot process effacement. Despite increasing knowledge of thee molecular composition of the glomerular filtration barrier, the relationship between proteinuria andd foot process effacement is unclear. We conducted a morphological study on the relationship betweenn podocyte foot process effacement and proteinuria. Electron microscope (EM) pictures of glomerularr capillaries were randomly taken from 27 cases in various stages of minimal change nephroticc syndrome (MCNS), from 6 cases of IgA nephropathy with high proteinuria (IgAN) and fromm 6 control kidneys. From each picture, the mean width of the foot processes (FPW) was quantitated.. In normal kidney the mean FPW was 580 40 nm. In biopsies from patients with MCNSS without treatment, foot processes were diffusely effaced, reflected by a FPW of 16000 440 nm. In biopsies from patients with MCNS relapsing under prednisolone treatment, foot processess were significantly less effaced than in untreated MCNS (FPW 920 200 nm). In biopsies displayingg IgAN, effacement was significantly more segmental than in untreated MCNS (FPWW 800 170 nm). Proteinuria did not differ significantly among the groups. Neither in MCNS norr in IgAN was the extent of foot process effacement correlated with the level of proteinuria. Thee differences in podocyte effacement between MCNS, MCNS relapsing under prednisolone treatment,, and IgAN may point to different mechanisms of podocyte injury in these diseases.
Podocytess are highly specialized epithelial cells that coverr the glomerular basement membrane with their numerouss interdigitating foot processes. In combinationn with the glomerular basement membranee (GBM), podocytes constitute the filtrationn barrier of the glomerular capillary wall. Proteinuriaa is associated with striking changes in podocytee architecture, as detected by electron microscopyy (EM). These changes comprise of loss orr effacement of the podocyte foot processes. Podocytee foot process effacement can be the solitary hallmarkk in the renal biopsy specimen, as in minimall change nephrotic syndrome (MCNS), or cann be accompanied by other abnormalities characteristicc of the underlying disease, such as immunee deposits, inflammation or fibrosis [1] . Whetherr a solitary lesion or not, podocyte foot processs effacement seems a uniform response of thee podocyte to injury. The etiology of this phenomenonn is as yet unknown, despite the rapid increasee in the knowledge of podocyte structure andd function over the last few years [2] . Furthermore,, how effacement of podocytes is relatedd to proteinuria and vice versa, is a matter of debate. . Too evaluate the relationship between proteinuria andd foot process effacement in human glomerular disease,, we conducted a morphological study on podocytee foot processes in renal biopsies obtained fromfrom 3 patient groups with proteinuric glomerulopathiess and in normal human kidney. Our findings mayy provide new insight in the etiology of foot processs effacement and proteinuria in human glomerulopathies. .
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Methods s
RenalRenal specimens and Electron Microscopy
Renall tissue was obtained for diagnostic purposes byy needle biopsies from 31 patients. The cases were diagnosedd as minimal change nephrotic syndrome (MCNS,, n=27), proteinuric IgA nephropathy (IgAN, n=6)) or normal 6-12 months after transplantation (controll group, n=6). Additional control human renall tissue was taken from an apparently unaffected partt of a kidney extirpated because of renal adenocarcinomaa (n=l). At the time of the biopsy, 13 MCNSS patients had not yet received any immunosuppressivee drugs, and 10 had relapsed underr treatment with methylprednisolone. Four MCNSS patients had achieved remission under treatmentt with methylprednisolone. Since these patientss experienced severe side effects, alternative treatmentt was considered and a control biopsy was performedd to exclude FSGS lesions.
Renall specimens were fixed in Karnovsky's fixative,, post-fixed in osmium tetroxide and embeddedd in epon (LADD Research Industries Inc., Williston,, VT). The EM sections were stained with uranyll acetate and lead citrate and examined with a CMM 10 electron microscope (Philips, Eindhoven, Thee Netherlands). For the present studies, 10 areas off 1 to 2 glomeruli in each patient were photographedd in a random and unbiased fashion and printedd on 23x23 cm paper, giving a final magnificationn of 11,000-fold. To study slit diaphragmm morphology, random photographs were takenn at a final magnification of 108,000-fold.
MeasurementMeasurement of podocyte foot process effacement andand proteinuria
Fromm each picture, the GBM was traced and measuredd in an image processing and analysis programm (Scion Corporation, Frederick, MD, USA). Thee number of podocyte foot processes along the GBMM was counted by hand. A foot process was definedd as any connected epithelial segment butting onn the basement membrane, between two neighboringg filtration pores or slits. From each photograph,, the arithmetic mean of the foot process widthh was calculated as follows:
^GBMength 44 /footprocess wheree £ foot process is the total number of foot processess counted in each picture, I GBM length is thee total GBM length measured in each picture, and thee correction factor of */4 serves to correct for presumedd random variation in the angle of section relativee to the long axis of the podocyte [3] . For eachh patient, the mean FPW was calculated and that valuee was used to finally calculate a mean FPW for eachh patient group. Inn all patients except the control group, proteinuriaa was determined by measuring 24-hrs excretionn of total protein into the urine. Total proteinn was turbidimetrically determined using benzethoniumchloride.. Urine was collected within twoo days prior to the biopsy. In the group of patients treatedd with steroids at the time of biopsy, proteinuriaa was also determined within two days afterr the biopsy to ensure that proteinuria was persistent.. In the control group, (absence of) albuminuriaa was determined using Albustix (Roche Diagnostics,, Almere, The Netherlands).
StatisticalStatistical analysis
Differencess between groups were determined by Kruskal-Walliss tests, followed by Mann-Whitney testss to calculate statistical significance. Differences weree considered as significant when P < 0.05. Correlationn analysis was performed using the Spearmann test.
Results s
Representativee pictures from each patient group are shownn in Figure 1 . From each case at least 400 urn GBMM was measured. The mean foot process width (FPW)) in the individual pictures ranged from minimallyy 430 nm to more than 6000 nm. In normal kidneys,, podocyte foot processes were well conserved,, yet segmental spreading of the processes wass present. The FPW in normal kidneys was 580 400 nm ( Figure 2A ), which is in accordance with the normall range described by others [4] [5] [6] . Podocyte foott processes from MCNS patients in remission, i.e.i.e. without proteinuria, were well conserved, resultingg in a mean FPW of 660 110 nm. In biopsiess from patients with active MCNS without treatmentt podocyte foot processes were diffusely effaced,, reflected by a mean FPW of 1630 440 nm.. In biopsies from patients with MCNS relapsing underr methylprednisolone treatment, podocyte foot processess were significantly more conserved than in untreatedd MCNS (FPW 920 200 nm, P < 0.001 versusversus untreated MCNS). In biopsies displaying IgAN,, effacement was moderate and segmental, withh a mean FPW of 805 170 nm (P = 0.001 versusversus untreated MCNS). Importantly, proteinuria didd not differ significantly between the proteinuric groupss (P = 0.38; Figure 2B ). The individual FPW valuess of proteinuric patients are shown in Figure 3 . Neitherr in active MCNS nor in IgAN, FPW was correlatedd to proteinuria (r = 0.05 for untreated MCNS,, P = 0.87.; r = 0.50 for MCNS under prednisolonee treatment, P = 0.11; r = -0.23 for IgAN,, P = 0.66). A correlation was also absent whenn all proteinuric MCNS patients were consideredd one group (r = 0.25, P = 0.25), or when alll proteinuric patients were grouped together (r(r = 0.34, P = 0.07). MCNSS has been reported to be associated not onlyy with podocyte foot process effacement, but alsoo with distortion of the slit diaphragms. In accordancee with reports by others [7, 8] , we observedd diffusely distorted filtration slits in our MCNSS patients, with displacement of the deformed slitss towards the apical cell membrane of the foot processess and the formation of occluding junctionall complexes between neighboring foot processess elsewhere ( Figure 4C) . Also, the interpedicall spaces were irregularly widened or evenn absent when junctions were formed. In contrast,, the changes in slit diaphragm morphology inn MCNS patients relapsing under prednisolone treatmentt were less extensive and limited to the effacedd podocyte foot processes. The slit diaphragmss that connected conserved foot processess appeared normal ( Figure 4D and E). Alsoo in IgAN patients, damage to the slit diaphragmss was only focal and mainly, apparently normall slits could be observed ( Figure 4F ).
Discussion n
Inn 1957, Farquhar el al. were the first to describe extensivee effacement of podocyte foot processes in biopsiess of patients with nephrotic syndrome [7] . Foott process effacement has since been documented byy many authors and has been subject of extensive investigationn in humans and in animal models. Despitee this, the pathogenesis of podocyte foot processs effacement and its relation to proteinuria are stilll not clear. Podocyte foot process effacement seemss a stereotypic reaction of podocytes to damage [1] .. In laboratory animals, there are various ways to inducee foot process effacement and proteinuria by injuringg podocytes. The velocity of development of foott process effacement and its severity differ betweenn the models. Examples are immunecomplexx mediated injury by complement in the Heymann-nephritiss model [9, 10] , direct toxic podocytee injury by puromycin aminonucleoside [11, 12] ] or adriamycin [13, 14] , and injury by injecting antibodiess directed against distinct epitopes on podocytes,, such as podoplanin [15] and aminopeptidasee A [16] . Studies on knock-out mice havee shown that also genetic disruption of genes encodingg structural components of the podocyte foot processs or slit diaphragm can lead to podocyte foot processs effacement and knock-out phenotypes have alsoo been identified in human forms of hereditary nephroticc syndromes (as reviewed in [17] ). Althoughh the initial cause leading to foot process effacementt in those models and diseases may seem evident,, its relation to the development of proteinuriaa is still not fully understood.
Thee pathogenic mechanism underlying podocyte foott process effacement in acquired nephrotic syndromes,, such as MCNS, primary focal segmental glomerulosclerosiss or nephrotic syndrome in the contextt of IgA nephropathy (IgAN) is unknown. In analogyy to animal models, different pathogenic mechanismss may underlie proteinuria and foot processs effacement also in acquired human glomerulopathies. . Duringg routine examination of electron micrographss of human renal biopsy tissue, we were struckk by differences in the degree of podocyte foot processs effacement in biopsies from nephrotic patientss with comparable levels of proteinuria. To validatee these differences and to further evaluate the relationshipp of podocyte foot process effacement andd proteinuria, this study was undertaken.
Morphometricc analysis confirmed that there weree significant differences in the degree of foot processs effacement between patients with MCNS, MCNSS relapsing under prednisolone treatment, and IgAN.. These differences however were independent off the level of proteinuria. Although an abnormal foott process width was invariably associated with proteinuria,, a rather large fraction of patients with relapsingg MCNS and IgAN presenting with gross proteinuriaa had only segmental to moderate effacementt of the podocyte foot processes. This is in linee with other studies, both in animals and in humans,, showing that proteinuria is not uniformly associatedd with podocyte foot process effacement. Afterr injection of monoclonal antibodies directed againstt slit diaphragm components nephrin or nephl,, rats rapidly develop proteinuria in the presencee of intact foot processes [18, 19] . Male MWFF rats develop spontaneous proteinuria with age,, without changes in the podocyte foot processes [20] .. In humans, a familial form of nephrotic syndromee has been reported to occur in the absence off effacement of the podocyte foot processes [21] andd in patients with glomerulonephritis, proteinuria iss not always associated with foot process effacementt [22] .
Wee did not find a correlation between proteinuria andd foot process effacement in nephrotic patients, in contrastt to two previous studies that described weak butt significant correlations between foot process effacementt and proteinuria in MCNS patients [4, 6] . Itt should be stated that the correlations in both studiess were calculated by considering all MCNS patientss as one group, i.e. including a significant numberr of patients who were treated with prednisolonee and patients achieving remission, therebyy presenting with proteinuria less than 1 g/24 hrs.. Only when we would also consider all MCNS patientss as one group, including patients in remissionn (without proteinuria), we would indeed findd a weak, yet significant correlation (r = 0.52; PP = 0.028). To our opinion, however, this only showss that in patients who achieve remission, podocytess return to their normal shape and that abnormall foot process width is invariably associated withh proteinuria.
Inn an attempt to explain the occurrence of proteinuriaa in the absence of extensive foot process effacement,, we studied the morphology of the podocytee slit diaphragms. The slit diaphragm representss an intercellular junction and not only formss a functional filter, but also establishes the contactt between two adjacent foot processes which aree derived from two different podocytes. The criticall role of the slit diaphragm in the maintenance off the glomerular filtration barrier is highlighted by thee discovery that forms of familial nephrotic syndromee are caused by aberrant expression of the slitt diaphragm constituents nephrin [23] and podocinn [24] ; genetic disruption of these and other slitt diaphragm components and intracellular slit diaphragmm linker proteins, such as nephl and CD2AP,, concordantly results in proteinuria in mice [25] [26] [27] [28] .. The pathogenic role of these slit diaphragm proteinss in MCNS, a nonfamilial disease, is still not elucidated.. Morphologically, the slit diaphragms in MCNSS biopsies are dislocated, apparently absent or replacedd by junctions ( [7, 8] , and Figure 4B ). In contrast,, we found that the slit diaphragms appeared largelyy preserved in the group of patients relapsing underr prednisolone treatment and in IgAN patients. Intactt slit diaphragms were observed in conjunction withh intact foot processes; only focally, damaged slit diaphragmss were present. Thus, in these patients, proteinuriaa could not be explained by overt damage too the podocyte slit diaphragms. We next examined glomerularr expression of podocin and nephrin by immunofluorescencee on cryostat sections that were availablee from the patients presented here. The expressionn of podocin appeared normal in all groups,, showing a linear distribution along the peripherall capillary loops of the glomeruli (not shown).. The distribution of nephrin showed also a linearr glomerular pattern in most groups. Only in patientss with untreated MCNS, the staining pattern off nephrin was altered into a more granular pattern (nott shown), which is in line with earlier studies [6] . Thus,, the differences in foot process effacement betweenn the groups reported here cannot be explainedd by differences in podocin expression. Furthermore,, nephrin protein expression appears to bee correlated with the extent of podocyte foot processs effacement.
Inn summary, our study confirms that proteinuria, foott process effacement and slit diaphragm damage aree associated, yet neither foot process effacement norr slit diaphragm damage seem to be a prerequisite forr proteinuria. The lack of correlation between proteinuriaa and foot process effacement renders an exclusivee causal relationship between podocyte foot processs effacement and proteinuria unlikely. A potentiall causal relationship may be present in the proteinn overload model, in which injection of rats withh large doses of bovine serum albumin causes proteinuriaa associated with podocyte foot process effacementt [29, 30] . The possibility of injury of podocytess by albumin itself cannot be excluded, yet ourr findings suggest that such a mechanism is not likelyy in the glomerulopathies studied here. The resultss support our hypothesis that the extent of foot processs effacement is determined by the mechanism off injury, supposing a different nature of podocyte injuryy in MCNS and IgAN. The latter may not be unexpected,, yet we also found striking differences betweenn MCNS patients relapsing under prednisolonee treatment and those not receiving prednisolonee at the time of biopsy. Patients frequentlyy relapsing under prednisolone treatment, oftenn referred to as steroid-dependent, make up aboutt 30% of the MCNS patients [31] and thus constitutee an important clinical problem. To maintainn remission these patients require high doses off steroids, resulting in toxic side-effects. It has recentlyy been shown that not only familial cases, but alsoo some sporadic cases of steroid-resistant nephroticc syndrome can be caused by mutations in thee gene encoding podocin [32] . Those patients usuallyy show no response to immunosuppressive treatmentt and progress to focal segmental glomerulosclerosis,, which was not observed in our patients.. Also, the renal expression of podocin was normall in our patients, as detected by immunofluorescencee (not shown). Therefore, the steroid-dependentt patients presented here seem to representt a distinct patient group, with a specific hallmarkk in the renal biopsy, i.e. limited foot processs effacement and preservation of slit diaphragms,, in the presence of proteinuria. In the futuree this feature might help to identify patients thatt require treatment different from steroids, such ass cyclosporine, cyclophosphamide and levamisole, andd thus deserves further investigation.
Inn conclusion, the severity of foot process effacementt in biopsies of nephrotic patients is dependentt on the nature of the underlying disease andd is independent on the level of proteinuria. It appearss that podocyte foot process effacement and proteinuriaa are independent sequelae of injury to the glomerularr filtration barrier. For acquired NS, the naturee of the initiating injury remains to be identified. .
